Subtitle 2c—Prescription Drug Affordability Board
- MD Health Gen T. 21, Subt. 2c, Refs & Annos
- § 21–2c–01. Definitions
- § 21–2c–02. Established; Purpose
- § 21–2c–03. Membership
- § 21–2c–04. Prescription Drug Affordability Stakeholder Council
- § 21–2c–05. Disclosure of Conflict of Interest
- § 21–2c–06. Acceptance of Gifts or Donations
- § 21–2c–07. Study of Aspects of Pharmaceutical Distribution and Payment; Report
- § 21–2c–08. Identifying Prescription Drug Products that Create Affordability Challenges for State Health Care System and Patients
- § 21–2c–09. Cost Review of Prescription Drug Products Identified in § 21–2c–08
- § 21–2c–10. Trade Secrets; Confidential and Proprietary Information
- § 21–2c–11. Annual Fee; Prescription Drug Affordability Fund
- § 21–2c–12. Enforcement of Subtitle
- § 21–2c–13. Process for Setting Upper Payment Limits for Prescription Drug Products that Lead to Affordability Challenges
- § 21–2c–14. Upper Payment Limits
- § 21–2c–15. Appeals
- § 21–2c–16. Report